Request a Duplicate Remittance Advice
SUBJECT | PROVIDER TYPE(S) | CYCLES | ALERT DATED |
|---|---|---|---|
| Revisions to Participating Drug Company list for Medicaid Drug Rebate Program | 07, 08, 09, 24, and 31 | 13, 14, 15, and 16 | 09/20/2024 - 10/22/2024 |
| Community Support Service Providers - Federal Financial Participation Rate Change and Continued Billing Requirements | 11/115; 21/221 and 21/222 | 11, 12, 13, and 14 | 09/06/2024 - 10/08/2024 |
| Changes to Electronic Funds Transfer (EFT) procedure | All | 01, 02, 03, 04, 05, 06, 07, and 08 | 06/28/2024-08/27/2024 |
Revisions to Participating Drug Company list for Medicaid Drug Rebate Program | 07, 08, 09, 24, and 31 | 01, 02, 03 and 04 | 06/28/2024 – 07/30/2024 |
All (Exception 07) | 52 | 06/24/2024 | |
| Fee-for-Service (FFS) Severity of Illness (SOI) Adjustments | 01/01 | 43, 44, and 45 | 04/20/2024-05/14/2024 |
| Fee-for-Service (FFS) Relative Weight Adjustments | 01/010 | 43, 44, and 45 | 04/20/2024-05/14/2024 |
| Revisions to Participating Drug Company list for Medicaid Drug Rebate Program | 07, 08, 24, and 31 | 39, 40, and 41 | 03/22/2024 - 04/16/2024 |
| Date of Death Recovery | All (Exception 07) | 33 | 02/14/2024 |
| Pharmacist Enrollment in Medical Assistance Program | 01, 07, 08, 10, 24, 31 | 33, 34, 35, and 36 | 02/14/2024 |
| EVV Communication Alert for HHCS | 05/050, 05/361, 05/362 16/160, 16/161 | 26, 27, 28, 29, 30, and 31 | 12/22/2023 - 02/06/2024 |
| Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 09, 24, & 31 | 26, 27, 28, and 29 | 12/22/2023 - 01/23/2024 |
05/050, 05/051, 05/361, 05/36216/160, 16/161 59/170, 59/171, 59/173, 59/160, 59/161 17/173, 17/171, 17/170 19/425 31/426 11/421, 11/422, 11/423, 11/424 | 20, 21, 22, 23, 24, 25, and 26 | 11/10/2023 - 01/02/2024 | |
All (exception 07) | 19 | 11/03/2023 | |
ALL | 16 | 10/13/2023 - 10/24/2023 | |
Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 09, 24, & 31 | 15, 16, and 17 | 10/06/2023 - 10/31/2023 |
ALL | 15, 16, 17, 18, 19, 20, 21, and 22 | 10/06/2023 - 12/05/2023 | |
11/115; 21/221 and 21/222 | 11, 12, 13, and 14 | 09/08/2023 - 10/10/2023 | |
Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 08, 24, & 31 | 01, 02, 03, and 04 | 06/30/2023 - 08/01/2023 |
01/010; Claim Types I and A | 52, 01, 02, and 03 | 06/23/2023 - 07/25/2023 | |
27 | 45, 46, 47, and 48 | 05/05/2023 - 05/30/2023 | |
ALL | 45, 46, 47, 48, 49, 50, 51, and 52 | 04/28/2023 - 06/27/2023 | |
Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 08, 24, & 31 | 39, 40 ,41, and 42 | 03/24/2023 - 04/25/2023 |
All (exception 07) | 36 | 03/06/2023 | |
Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 08, 24, & 31 | 26, 27, 28, and 29 | 12/23/2022 - 01/24/2023 |
ALL | 13, 14, 15, and 16 | 09/23/2022 - 10/25/2022 | |
Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 09, 24, & 31 | 13, 14, 15, and 16 | 09/23/2022 - 10/25/2022 |
06/060 | 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, and 22 | 09/16/2022 - 11/30/2022 | |
ALL | 11 and 12 | 09/09/2022 - 09/27/2022 | |
11/115; 21/221 and 21/222 | 11, 12, 13, and 14 | 09/09/2022 - 10/11/2022 | |
Corrections to Cycle 07 & 66 Credits (Accounts Receivables) recoupments | Specific Providers | 10 | 09/02/2022 - 09/13/2022 |
All (exception 07) | 08 | 08/22/2022 | |
ALL | 66 | 08/15/2022 - 08/18/2022 | |
| Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 09, 24 & 31 | 52, 01 and 02 | 06/24/2022 - 07/19/2022 |
All (exception 07) | 43 & 44 | 04/25/2022 | |
New Procedure Codes added to PA Medical Assistance Program Fee Schedule | 05/050 | 43 | 04/21/2022 - 05/03/2022 |
ALL | 41, 42, 43, 44, 45 and 46 | 04/08/2022 - 05/24/2022 | |
Ordering, Referring and Prescribing Provider Enrollment Requirements | ALL | 40,41, 42, 43, 44 and 45 | 04/01/2022 - 05/17/2022 |
Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 09, 24 & 31 | 39, 40 and 41 | 03/25/2022 - 04/19/2022 |
Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 09, 24 & 31 | 26, 27 and 28 | 12/24/2021 - 01/11/2022 |
Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 09, 24 & 31 | 13, 14, 15 and 16 | 09/24/2021 - 10/19/2021 |
All | 12, 13, 14, 15 and 16 | 09/17/2021 | |
11/115, 21/221 and 21/222 | 11, 12, 13 and 14 | 09/08/2021 | |
Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 09, 24 & 31 | 52, 01 and 02 | 06/24/2021 |
Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 09, 24 & 31 | 39, 40 and 41 | 03/22/2021 |
Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 09, 24 & 31 | 26, 27 and 28 | 12/16/2020 |
Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 09, 24 & 31 | 13, 14 and 15 | 09/22/2020 |
11/115, 21/221 and 21/222 | 11, 12, 13 and 14 | 08/26/2020 | |
07/072 | 07 | 08/12/2020 | |
Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 09, 24, & 31 | 01, 02 and 03 | 06/26/2020 |
Pharmacy Fee-for-Service Claims with COVID-19 Related Outpatient Drugs/Drug Classes | 24 | 50, 51 and 52 | 06/05/2020 |
Reprocessing of Fee-for-Service Claims with COVID19 related Diagnosis code and Copay collection | All | 47 | 05/13/2020 |
01/010 | 40, 41, & 42 | 03/26/2020 | |
Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 09, 24, & 31 | 40, 41, & 42 | 03/26/2020 |
All | 39, 40 | 03/20/2020 | |
01/010 | 39, 40, 41 | 03/20/2020 | |
All (exception 07) | 19 | 11/01/2019 | |
07, 08, 09, 24, & 31 | 19, 20, 21, 22, 23, 24, 25, 26, 27 | 11/01/2019 - 12/31/2019 | |
Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 09, 24, & 31 | 14, 15 and 16 | 09/27/2019 - 10/15/2019 |
11/115, 21/221 and 21/222 | 12, 13, 14, 15 | 09/13/2019 - 10/08/2019 | |
Revisions to Participating Drug Company list for Medicaid Drug Rebate Program | 07, 08, 09, 24, & 31 | 01, 02, 03 | 07/ 28/2019 - 07/16/2019 |
Provider Type/Specialty: 01/010, 011, 013, 018, 019, 022, 183, 370, 441; 05/370; 07/072; 08/074, 076, 080, 081, 082, 083, 084, 110, 184, 340, 370, 558, 800, 801, 802, 803, 804, 805, 806, 807, 808, 809, 810, 811; 09/093, 103, 370, 548, 549, 558, 559; 11/076, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 123, 127, 128, 129, 131, 132, 133, 134, 184, 340, 442, 443, 444, 445, 446, 447, 448, 449, 450, 451, 452, 453, 548, 549, 558, 559, 561, 562; 16/162; 17/171, 174, 175; 19/190, 370, 548, 549, 558, 559; 21/076, 138, 212, 221, 222; 27/370; 31/315, 316, 322, 339, 345, 370, 548, 549, 558, 559; 37/370; 52/520, 523; 56/560 | 02, 03, 04 | 07/05/2019 - 07/23/2019 | |
All (exception 07) | 42 | 04/12/2019 | |
Provider Specific: 102016236-0002, 102286948-0006, 001101797-0003, 001833233-0003, 100748293-0136, 102707271-0001, 100748293-0058, and 100735393-0010; Claim Types: All | 42 | 04/12/2019 | |
Revisions to Participating Drug Company list for Medicaid Drug Rebate Program | 07, 08, 09, 24, 31 | 40, 41, 42 | 03/29/2019 - 04/16/2019 |
01/010; Claim Types I and A | 39, 40, 41 | 03/22/2019 - 04/09/2019 | |
Implementation of the All-Patient Refined Diagnosis Related Group version 36 | 01/010; Claim Types I and A | 35, 36, 37 | 02/22/2019 - 03/12/2019 |
All | 30 through 52 | 01/18/2019 - 07/02/2019 | |
Revisions to Participating Drug Company list for Medicaid Drug Rebate Program | 07, 08, 09, 24, 31 | 27, 28, 29 | 12/26/2018 - 01/15/2019 |
Reprocessing of Fee-for-Service Claims for Community Health Choices (CHC) Recipients | All | 19 | 11/02/2018 |
All (exception 07) | 16 | 10/12/2018 | |
Deadline Extension for $193,000 in Incentives for Implementing Opioid Guidelines | 01/010 | 16, 17, 18, 19, 20, 21, 22, 23 | 10/12/2018 - 12/04/2018 |
Revisions to Participating Drug Company List for Medicaid Drug Rebate Program | 07, 08, 09, 24, 31 | 14, 15, 16, 17 | 09/28/2018 - 10/23/2018 |
All | 12, 13, 14, 15, 16 | 09/14/2018 - 10/16/2018 | |
11/115; 21/221 and 21/222 | 12, 13, 14, 15, 16 | 09/14/2018 - 10/16/2018 | |
Deadline Approaching for $193,000 in Incentives for Implementing Opioid Guidelines | 01/010 | September 14, 2018 through October 2, 2018 | 09/14/2018 |
Reprocessing of Fee-for-Service Claims for Community Health Choices (CHC) Recipients | All | 01 | 06/29/18 - 07/03/18 |
All | 03, 04, 05, 06, 07, 08, 09, 10 | 07/06/18 - 09/04/18 | |
Revisions to Participating Drug Company list for Medicaid Drug Rebate Program | 07, 08, 09, 24, 31 | 52, 01, 02 | 06/22/18 - 07/06/18 |
All | 49, 50, 51, 52, 01,02, 03, 04, 05 | 06/01/18 - 07/31/18 | |
01/010; Claim Types I, A | 41, 42, 43 | 04/06/2018 | |
Revisions to Participating Drug Company list for Medicaid Drug Rebate Program | 07, 08, 09, 24, 31 | 40, 41, 42 | 03/30/2018 |
All (exception 07) | 40 | 03/30/2018 | |
Specific Providers | 38, 39 | 03/17/2018 | |
All – except 35, 65, and 70; Provider Specialties - All; Claim Types - All | 38, 39, 40, 41 | 03/16/2018 | |
Implementation of the All-Patient Refined Diagnosis Related Group version 35 | 01/010; Claim Type I | 35, 36, 37 | 02/23/2018 |